U.S. Chemicals Stock News

In late May 2026, the U.S. National Oceanic and Atmospheric Administration (NOAA) certified TMC USA’s application to explore a 122,000-square-kilometer seabed area estimated to contain about 1.02 billion tonnes of polymetallic nodules rich in nickel, cobalt, copper, manganese and rare earth elements, and began preparing an Environmental Impact Statement for the planned activities. This regulatory milestone moves TMC the metals further into the U.S. permitting framework for deep-sea minerals,...

The United States market has shown robust performance recently, with a 1.6% increase over the last week and a substantial 28% rise over the past year, while earnings are anticipated to grow by 17% annually in the coming years. In this favorable environment, identifying high growth tech stocks involves looking for companies that demonstrate strong innovation potential and scalability to capitalize on these positive market conditions.

The United States market has shown robust performance, rising 1.6% over the last week and surging 28% over the past year, with earnings forecasted to grow by 17% annually. In this environment, identifying stocks trading at significant discounts can offer potential opportunities for investors looking to capitalize on undervaluation relative to market growth expectations.

In the past week, the United States market has seen a 1.6% increase and is up an impressive 28% over the last year, with earnings projected to grow by 17% annually in the coming years. In this thriving environment, identifying growth companies with significant insider ownership can be crucial as it often indicates confidence from those closest to the business and aligns their interests with shareholders.

The market has climbed 1.6% in the last 7 days, contributing to a remarkable 28% increase over the past year, with earnings expected to grow by 17% per annum in the coming years. Though 'penny stock' might sound like a relic of past trading days, it still points to opportunities in smaller or newer companies that can offer significant returns when built on solid financials. We've identified three penny stocks that combine balance sheet strength with potential for outsized gains, offering...

The United States market has shown resilience with a 1.6% increase in the past week and an impressive 28% rise over the last year, supported by forecasts of annual earnings growth at 17%. In this dynamic environment, identifying promising small-cap stocks that align with these positive trends can offer unique opportunities for investors seeking to uncover potential growth stories.

The United States market has shown robust performance recently, climbing 1.6% in the last week and 28% over the past year, with earnings anticipated to grow by 17% annually. In this thriving environment, selecting dividend stocks that offer reliable income and potential for capital appreciation can be a prudent strategy for investors seeking stability and growth.

If you are wondering whether FedEx at around US$411.75 is still offering value after a strong run, the key is to look closely at what the current price implies about the company. The stock has posted returns of 4.5% over the past week, 4.6% over the past month, 40.5% year to date and 93.2% over the past year, which naturally raises questions about growth potential and how much risk is already priced in. Recent coverage has focused on FedEx as a major global logistics player, with attention...

The Goodyear Tire & Rubber Company recently issued US$750 million of senior, unsecured corporate notes due July 15, 2032, featuring attached guarantees and call provisions. This sizeable fixed-income offering sheds light on how Goodyear is managing its capital structure and future financing flexibility alongside its broader operations. Next, we’ll examine how this US$750 million senior unsecured bond issue could influence Goodyear’s investment narrative and balance sheet outlook. Find 46...

What triggered fresh interest in Dycom Industries stock? Dycom Industries (DY) drew fresh attention after reporting a strong first quarter, raising full-year and second-quarter revenue guidance, and announcing an agreement to acquire National Technology Integrators in the data center space. See our latest analysis for Dycom Industries. The stock has cooled slightly after the earnings spike, with the latest 1 day share price return down 4.7%. However, a 7 day share price return of 24.0% and a...

Conference spotlight and recent share performance Onto Innovation (ONTO) is set to present at TD Cowen's 54th Annual Technology, Media & Telecom Conference on May 27, 2026, an event that has drawn fresh attention to the stock. With the share price at US$258.24 at the last close and mixed short term returns, recent interest centers on how conference commentary might shape views on the business, valuation and overall company profile. See our latest analysis for Onto Innovation. Onto...

In May 2026, Ryan Specialty Holdings increased its equity repurchase authorization by US$300 million to a total of US$600 million and prepared to showcase its specialty insurance platform at the William Blair Growth Stock Conference. Institutional investor Guardian Point Capital’s additional 75,000-share purchase, alongside strong first-quarter revenue and earnings growth, underscored growing confidence in Ryan Specialty’s technology- and data-focused model. With expanded buyback capacity...

Wyndham Hotels & Resorts recently launched a native ChatGPT app, enabling travelers to explore its roughly 8,400‑hotel portfolio with conversational AI, while also announcing that Chief Accounting Officer Nicola Rossi will leave on July 31, 2026, to be succeeded by longtime finance executive Christopher Androski. This combination of AI-driven booking capabilities and an internally sourced leadership transition in a core finance role highlights Wyndham’s emphasis on both digital innovation...

Why Oscar Health is on investors’ radar today Oscar Health (OSCR) is attracting fresh attention after recent trading, with the stock last closing at US$22.23. Investors are weighing this price against the company’s recent returns and fundamentals. See our latest analysis for Oscar Health. Recent trading has been choppy, with the share price down 0.45% over the last day and 1.81% over the week. Even so, the 30 day share price return of 20.23% and year to date share price return of 48.5% sit...

Biogen Inc. and Denali Therapeutics Inc. recently reported that their Phase 2b LUMA study of BIIB122 in early-stage Parkinson’s disease failed to meet its primary and secondary efficacy endpoints, leading them to discontinue development of the drug for idiopathic Parkinson’s disease while continuing a separate Phase 2a study in LRRK2 variant carriers. Despite missing clinical endpoints, the trial confirmed strong target engagement with high peripheral LRRK2 kinase inhibition and CSF...

Pilgrim's Pride recently reported fiscal first-quarter 2026 results showing sales growth across several segments but weaker overall profitability and an earnings miss. Within these mixed results, the Just Bare brand stood out with very strong year-over-year sales growth, supported by ongoing investment in new facilities. Now we’ll examine how the profit pressure alongside Just Bare’s rapid expansion could influence Pilgrim’s Pride’s broader investment narrative. The best AI stocks today may...

Cognizant Technology Solutions recently expanded its AI footprint by partnering with Travelport to embed Anthropic’s Claude into travel retail platforms and by launching agent-powered Electronic Prior Authorization APIs on its TriZetto Unify healthcare platform, extending AI deeper into both travel and U.S. healthcare workflows. By exposing TriZetto services as headless, agent-ready APIs aligned with HL7 FHIR standards and supporting the Model Context Protocol, Cognizant is positioning its...

In recent days, Moderna announced an expanded collaboration with the Coalition for Epidemic Preparedness Innovations (CEPI), which will provide up to US$50 million to support preclinical and Phase 1 development of its investigational Bundibugyo ebolavirus (BDBV) vaccine candidate. This partnership highlights how Moderna is using its mRNA platform beyond respiratory viruses, extending into emerging infectious diseases such as Ebola during an active outbreak in the Democratic Republic of...

Aura Minerals (AUGO) put its growth plans in front of investors during a Renmark virtual non deal roadshow on May 25, outlining recent production gains, new assets and progress on development projects. See our latest analysis for Aura Minerals. The Renmark roadshow comes after a mixed stretch for the stock, with a 1-day share price return of 1.83% and 7-day share price return of 6.46%. However, the 30-day share price return fell 5.95%, while a year-to-date share price return of 54.54% and a...

AeroVironment recently faced investor lawsuits and a terminated BADGER antenna contract for the Space Force’s SCAR program, while also securing several new U.S. government awards, including a US$20.2 million investment to expand its Huntsville missile facility and a US$20 million Air Force Research Laboratory CAMP materials contract. This mix of legal and program risk alongside fresh funding for counter‑UAS production, advanced materials, and AV_Halo software underscores how dependent...

Why Zai Lab (ZLAB) is on investors’ radar Zai Lab (ZLAB) has been drawing attention after recent share price pressure, with the stock down 4.3% over the past day and 17.9% over the past month, prompting investors to reassess its fundamentals. At a recent close of US$17.69 and a market value of about US$2.0b, the biopharmaceutical company reports annual revenue of US$453.28 million and a net loss of US$178.12 million, reflecting an early stage earnings profile. See our latest analysis for Zai...

Elanco Animal Health has begun a phased U.S. launch of Befrena (tirnovetmab), an anti‑IL‑31 monoclonal antibody injection for canine allergic and atopic dermatitis, offering 6 to 8 weeks of itch relief and rapid onset in Early Experience Program clinics. The product expands Elanco’s dermatology and monoclonal antibody lineup, making it the only pet health company with two USDA‑approved mAb therapies and broadening its presence in pet allergy care. We’ll now examine how Befrena’s...

Cisco Systems recently filed a US$41.20 million shelf registration for 342,185 common shares tied to its employee stock ownership plan and continued to report strong quarterly results supported by AI-focused networking and infrastructure demand. Automation Anywhere’s launch of EnterpriseClaw, developed in collaboration with Cisco, NVIDIA, Okta, and OpenAI, highlights Cisco’s push to embed its AI Defense capabilities directly into next-generation enterprise AI agent workflows. Next, we’ll...

Parsons Corporation recently announced that Los Angeles Metro has opened Section 1 of the D Line Subway Extension, for which Parsons served as lead designer on 3.9 miles of new subway and three underground stations between Los Angeles and Beverly Hills. The company also secured a US$99 million, multi‑year task order from the U.S. Air Force Research Laboratory to advance command‑and‑control and space intelligence software, underscoring its role in high‑end digital defense solutions. Next,...